GENEVA, July 31 -- PARR BIOTECHNOLOGY (HEBEI) CO., LTD. filed a patent application (CN2025/147420) for “PHARMACEUTICAL COMPOSITION AND COMBINATION FORMULATION FOR IMMUNOTHERAPY OF CANCER, PHARMACEUTICAL USE, AND TREATMENT METHOD”. With publication no. WO/2026/157846, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....